文献速递外周动脉疾病

当代全国队列中下肢旁路术和血管内介入治疗严重肢体缺血未能达到血管外科学会肢体相关结局的客观性能目标

Lower extremity bypass and endovascular intervention for critical limb ischemia fail to meet Society for Vascular Surgery's objective performance goals for limb-related outcomes in a contemporary national cohort.
PubMed 文献 · J Vasc Surg · 2018-06-21

该研究将2011至2015年NSQIP血管靶向模块中11,043例严重肢体缺血血运重建的30天安全结局与2009年SVS基于随机试验制定的客观性能目标(OPG)比较,发现下肢旁路术和腹股沟下血管内介入治疗的肢体相关安全结局均未达到OPG基准,而心血管并发症发生率低于OPG基准。

要点

  • NSQIP下肢旁路术和血管内介入治疗的30天主要不良肢体事件均显著高于SVS OPG队列。
  • 两队列30天主要不良心血管事件均显著低于SVS OPG队列。
  • 高解剖风险患者中下肢旁路术和血管内介入治疗的30天主要不良肢体事件仍显著高于OPG基准。

核心结论

  • 在当代真实世界实践中,针对严重肢体缺血的下肢旁路术和血管内介入治疗在整体队列及高解剖风险患者中均未达到SVS OPG肢体相关30天安全基准。
  • 下肢旁路术和血管内介入治疗在30天心血管并发症发生率和死亡率方面优于OPG基准。
  • 作者认为需使用SVS OPG作为一致终点进一步研究以明确严重肢体缺血血运重建后肢体相关结局仍不理想的原因。
  • 作者认为严重肢体缺血血运重建患者的心血管并发症OPG值得用当代数据重新评估。

研究设计与样本

  • 研究将SVS OPG标准应用于2011至2015年国家外科质量改进计划(NSQIP)血管靶向模块中11,043例严重肢体缺血血运重建。
  • 分析队列包括NSQIP下肢旁路术(n=3833)和血管内介入治疗(n=3526),以及高解剖风险(膝下血运重建)和高临床风险(年龄>80岁且组织缺损)亚组。
  • 采用χ2检验将上述队列的30天安全OPG与SVS OPG基准进行比较。

主要发现

  • 与SVS OPG队列相比,NSQIP下肢旁路术队列高解剖风险患者比例较低(51% vs 60%,P<.0001),血管内介入治疗队列亦较低(27% vs 60%,P<.0001)。
  • 下肢旁路术队列高临床风险患者比例低于SVS OPG队列(11% vs 16%,P<.0001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: In 2009, the Society for Vascular Surgery (SVS) developed objective performance goals (OPGs) to define the therapeutic benchmarks in critical limb ischemia (CLI) based on outcomes from randomized trials of lower extremity bypass (LEB). Current performance relative to these benchmarks in both LEB and infrainguinal endovascular intervention (IEI) remains unknown. The objective of this study was to determine whether LEB and IEI performed for CLI in a contemporary national cohort met OPG 30-day safety thresholds. METHODS: SVS OPG criteria were applied to 11,043 revascularizations for CLI performed from 2011 to 2015 in the National Surgical Quality Improvement Program (NSQIP) vascular targeted modules. Primary 30-day safety OPGs including major adverse cardiovascular events (MACEs), major adverse limb events (MALEs), and amputation were calculated for the NSQIP LEB (n = 3833) and IEI (n = 3526) cohorts as well as for subgroups at "high anatomic risk" (infrapopliteal revascularization) and "high clinical risk" (age >80 years and tissue loss). These were compared with SVS OPG benchmarks using χ2 comparisons. RESULTS: Compared with the SVS OPG cohort, both the NSQIP LEB and IEI cohorts had fewer patients at high anatomic risk (LEB, 51%; IEI, 27%; SVS OPG, 60%; both P < .0001). The LEB cohort had fewer patients with high clinical risk than the SVS OPG cohort (LEB, 11%; SVS OPG, 16%; P < .0001). The 30-day MALE was significantly higher in the NSQIP LEB (9.0% [8.7%-9.2%]) and IEI (9.7% [9.4%-10.0%]) cohorts compared with the SVS OPG cohort (6.1% [4.7%-9.0%]; both P ≤ .007), including significantly higher rates of amputation. MACE was significantly lower in the NSQIP LEB (4.2% [4.1%-4.3%]) and IEI (3.1% [3.0%-3.2%]) cohorts compared with the SVS OPG cohort (6.1% [4.7%-8.1%]; both P ≤ .013). Among patients at high anatomic risk, 30-day MALE was significantly higher after LEB (9.5% [9.1%-9.8%]) and IEI (11.1% [10.4-11.8%]) compared with the SVS OPG cohort (6.1% [4.2%-8.6%]; P ≤ .002). Among patients with high clinical risk, IEI was associated with lower MACE compared with the SVS OPG cohort, with similar limb-related outcomes. CONCLUSIONS: In contemporary real-world practice, LEB and IEI for CLI failed to meet SVS OPG limb-related 30-day safety benchmarks for the entire CLI cohort as well as for the patients at high anatomic risk. Additional investigation using SVS OPGs as consistent end points is required to determine why limb-related outcomes after revascularization for CLI remain suboptimal. LEB and IEI surpassed OPG benchmarks for 30-day cardiovascular morbidity and mortality. OPGs for cardiovascular morbidity in patients undergoing revascularization for CLI deserve re-evaluation using contemporary data.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Robinson WP, Mehaffey JH, Hawkins RB, et al. Lower extremity bypass and endovascular intervention for critical limb ischemia fail to meet Society for Vascular Surgery's objective performance goals for limb-related outcomes in a contemporary national cohort. J Vasc Surg. 2018. PMID: 29937289. doi:10.1016/j.jvs.2018.03.413

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。